Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Central nervous system diseases
  • Active substance : zolmitriptan
  • Active substance : sumatriptan
Filter
Topic
  • Diseases and conditions (1)
  • Plus ...
    • Mental disorders and behavioural conditions (1)
    • Plus ...
      • Substance-related disorders (1)
    • Nervous system diseases (1)
    • Plus ...
      • Central nervous system diseases (1)
    • Pain - Inflammation (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Language
  • Français (1)
Active substance
  • alcool (1)
  • amitriptyline (1)
  • aspirine (1)
  • naratriptan (1)
  • nicotine (1)
  • sodium (1)
  • sumatriptan (1)
  • valproate de sodium (1)
  • zolmitriptan (1)

Practice guidelines and other guides - 1 result

  • Chronic daily headache (CDH) – Diagnosis, medication overuse, and management

    Practice guidelines - Posted on 1/9/2004
    Download abstract
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
j1EUZ4zw2b4S2awc